Advertisement
New Zealand markets close in 3 hours
  • NZX 50

    11,782.61
    -53.43 (-0.45%)
     
  • NZD/USD

    0.5867
    -0.0039 (-0.66%)
     
  • NZD/EUR

    0.5518
    -0.0027 (-0.48%)
     
  • ALL ORDS

    7,780.20
    -118.70 (-1.50%)
     
  • ASX 200

    7,525.20
    -116.90 (-1.53%)
     
  • OIL

    85.64
    +2.91 (+3.52%)
     
  • GOLD

    2,424.90
    +26.90 (+1.12%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,100.98
    -284.89 (-1.74%)
     
  • NIKKEI 225

    36,878.82
    -1,200.88 (-3.15%)
     
  • NZD/JPY

    90.4500
    -0.8040 (-0.88%)
     

Can Pfizer Beat GSK and Moderna in This $10 Billion Market?

Can Pfizer Beat GSK and Moderna in This $10 Billion Market?

Pfizer (NYSE: PFE) and GSK (NYSE: GSK) have competed against each other for years. Moderna (NASDAQ: MRNA) is a more recent rival, with its COVID-19 vaccine, SpikeVax, going head to head with Pfizer's Comirnaty. Can Pfizer beat GSK and Moderna in this $10 billion market?